473 related articles for article (PubMed ID: 9034998)
1. Synovial membrane inflammation and cytokine production in patients with early osteoarthritis.
Smith MD; Triantafillou S; Parker A; Youssef PP; Coleman M
J Rheumatol; 1997 Feb; 24(2):365-71. PubMed ID: 9034998
[TBL] [Abstract][Full Text] [Related]
2. Synovial inflammation in patients with early osteoarthritis of the knee.
Myers SL; Brandt KD; Ehlich JW; Braunstein EM; Shelbourne KD; Heck DA; Kalasinski LA
J Rheumatol; 1990 Dec; 17(12):1662-9. PubMed ID: 2084242
[TBL] [Abstract][Full Text] [Related]
3. Effect of IL-13 on cytokines, cytokine receptors and inhibitors on human osteoarthritis synovium and synovial fibroblasts.
Jovanovic D; Pelletier JP; Alaaeddine N; Mineau F; Geng C; Ranger P; Martel-Pelletier J
Osteoarthritis Cartilage; 1998 Jan; 6(1):40-9. PubMed ID: 9616438
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory cytokine profiles associated with chondral damage in the anterior cruciate ligament-deficient knee.
Marks PH; Donaldson ML
Arthroscopy; 2005 Nov; 21(11):1342-7. PubMed ID: 16325085
[TBL] [Abstract][Full Text] [Related]
5. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
[TBL] [Abstract][Full Text] [Related]
6. The role of cytokines in osteoarthritis pathophysiology.
Fernandes JC; Martel-Pelletier J; Pelletier JP
Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
[TBL] [Abstract][Full Text] [Related]
7. Disease-Modifying Osteoarthritis Treatment With Interleukin-1 Receptor Antagonist Gene Therapy in Small and Large Animal Models.
Nixon AJ; Grol MW; Lang HM; Ruan MZC; Stone A; Begum L; Chen Y; Dawson B; Gannon F; Plutizki S; Lee BHL; Guse K
Arthritis Rheumatol; 2018 Nov; 70(11):1757-1768. PubMed ID: 30044894
[TBL] [Abstract][Full Text] [Related]
8. Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis.
Deleuran BW; Chu CQ; Field M; Brennan FM; Katsikis P; Feldmann M; Maini RN
Br J Rheumatol; 1992 Dec; 31(12):801-9. PubMed ID: 1458286
[TBL] [Abstract][Full Text] [Related]
9. Synovial tissue inflammation in early and late osteoarthritis.
Benito MJ; Veale DJ; FitzGerald O; van den Berg WB; Bresnihan B
Ann Rheum Dis; 2005 Sep; 64(9):1263-7. PubMed ID: 15731292
[TBL] [Abstract][Full Text] [Related]
10. Synovial inflammation in patients with different stages of knee osteoarthritis.
Ene R; Sinescu RD; Ene P; Cîrstoiu MM; Cîrstoiu FC
Rom J Morphol Embryol; 2015; 56(1):169-73. PubMed ID: 25826502
[TBL] [Abstract][Full Text] [Related]
11. Osteoarthritis and rheumatoid arthritis pannus have similar qualitative metabolic characteristics and pro-inflammatory cytokine response.
Furuzawa-Carballeda J; Macip-Rodríguez PM; Cabral AR
Clin Exp Rheumatol; 2008; 26(4):554-60. PubMed ID: 18799084
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 is not involved in synovial inflammation and cartilage destruction in collagenase-induced osteoarthritis.
van Dalen SC; Blom AB; Slöetjes AW; Helsen MM; Roth J; Vogl T; van de Loo FA; Koenders MI; van der Kraan PM; van den Berg WB; van den Bosch MH; van Lent PL
Osteoarthritis Cartilage; 2017 Mar; 25(3):385-396. PubMed ID: 27654963
[TBL] [Abstract][Full Text] [Related]
13. Synovitis in osteoarthritis: current understanding with therapeutic implications.
Mathiessen A; Conaghan PG
Arthritis Res Ther; 2017 Feb; 19(1):18. PubMed ID: 28148295
[TBL] [Abstract][Full Text] [Related]
14. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of rheumatoid arthritis is associated with a reduction in synovial membrane cytokines and cell adhesion molecule expression.
Smith MD; Slavotinek J; Au V; Weedon H; Parker A; Coleman M; Roberts-Thomson PJ; Ahern MJ
Rheumatology (Oxford); 2001 Sep; 40(9):965-77. PubMed ID: 11561106
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of IL-1 and TNF receptors in inflammatory arthritis and osteoarthritis.
Ruggeri R; Pulsatelli L; Melchiorri C; Da Re R; Focherini MC; Veronesi M; Facchini A
Boll Soc Ital Biol Sper; 1996; 72(1-2):15-20. PubMed ID: 8868110
[TBL] [Abstract][Full Text] [Related]
17. Dkk-1 promotes angiogenic responses and cartilage matrix proteinase secretion in synovial fibroblasts from osteoarthritic joints.
Weng LH; Ko JY; Wang CJ; Sun YC; Wang FS
Arthritis Rheum; 2012 Oct; 64(10):3267-77. PubMed ID: 22736200
[TBL] [Abstract][Full Text] [Related]
18. Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease.
Scanzello CR; Umoh E; Pessler F; Diaz-Torne C; Miles T; Dicarlo E; Potter HG; Mandl L; Marx R; Rodeo S; Goldring SR; Crow MK
Osteoarthritis Cartilage; 2009 Aug; 17(8):1040-8. PubMed ID: 19289234
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of cartilage shards in synovium and their association with synovitis in patients with early and endstage osteoarthritis.
Myers SL; Flusser D; Brandt KD; Heck DA
J Rheumatol; 1992 Aug; 19(8):1247-51. PubMed ID: 1404161
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of metalloproteases and interleukin 6 (IL-6) in human osteoarthritic synovial membrane is an IL-1 mediated process.
Pelletier JP; McCollum R; Cloutier JM; Martel-Pelletier J
J Rheumatol Suppl; 1995 Feb; 43():109-14. PubMed ID: 7752112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
